CAS No. 145204-53-1

H-THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH

Catalog No.: 825153
Name: H-THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH
CAS: 145204-53-1
Formula: C81H126N20O22

Filed under: Peptide

Inquire about this product → | Safety data

About H-THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH

H-THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH is a chemical compound registered under CAS number 145204-53-1, with the molecular formula C81H126N20O22 and a molecular weight of about 1731.99 g/mol. It is also known as CARCINOEMBRYONIC ANTIGEN (101-115); CARCINOEMBRYONIC ANTIGEN FRAGMENT 101-115; CEA (101-115). ChemGloble supplies H-THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH for laboratory research and bulk production; product code 825153. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 145204-53-1
Molecular Formula: C81H126N20O22
Molecular Weight: 1731.99 g/mol

Synonyms

CARCINOEMBRYONIC ANTIGEN (101-115)
CARCINOEMBRYONIC ANTIGEN FRAGMENT 101-115
CEA (101-115)
THR-GLY-GLN-PHE-ARG-VAL-TYR-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE
CARCINOEMBRYONIC ANTIGEN FRAGMENT 101-

Phosphoric acid, C6-10-branched and linear alkyl esters, compds. with ethanolamine

Pyridine, 5-butoxy-2-(4-hexylphenyl)-

3,7-Diazabicyclo[3.3.1]nonane, 3-cyano-7-(phenylmethyl)-

3,7-Diazabicyclo[3.3.1]nonane,3-(6-chloro-3-pyridazinyl)-7-(phenylmethyl)-

3,7-Nonanedione, 5-[(acetyloxy)amino]-2,2,5,8,8-pentamethyl-

3-Quinolinecarboxamide, 4-hydroxy-6-(1-methylethyl)-N-2-thiazolyl-

64321-59-1

3,7-Dioxa-2,5-diazabicyclo[2.2.1]hept-5-ene, 1-methoxy-2-methyl-

3,8-Cyclotetradecadiyne-1-carboxylic acid,7-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-12-(1-methylethenyl)-5,14-dioxo-, 1,1-dimethylethyl ester, (12S)-

3,9-Diazabicyclo[4.2.1]nonane, 3-(3-pyridinyl)-, (1R,6S)-

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-7-[4-(3,6-dihydro-1(2H)-pyridinyl)butoxy]-6-methoxy-

3-Quinolinecarboxaldehyde, 1,2-dihydro-4-hydroxy-1-methyl-2-oxo-,3-[[6-(1,2-dihydro-4-hydroxy-2-oxobenzo[h]quinolin-3-yl)-1,2,4-triazin-3-yl]hydrazone]

3,7-Diazabicyclo[3.3.1]nonane-3-carbonitrile,7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-

389886-23-1

3-Quinolinecarboxaldehyde, 1,2-dihydro-4-hydroxy-2-oxo-1-phenyl-,3-oxime

TNF-α inhibitor

3,9-Diazabicyclo[4.2.1]nonane, 3-(6-chloro-5-methyl-3-pyridinyl)-,(1S,6R)-

3,8-Dioxa-1,6-diazabicyclo[4.4.1]undecane-5,10-dicarboxylic acid,4,9-dimethyl-, dimethyl ester, (1S,4R,5S,6S,9R,10S)-

3-Quinolinecarboxamide, 1-ethyl-5-fluoro-1,4-dihydro-4-oxo-N-propyl-

(3-chloro-6-fluoro-quinolin-4-yl)-acetic acid ethyl ester

1192282-68-0

3,9-Dioxa-2,10-disilaundecane,2,2,10,10-tetramethyl-5,5-bis(2,3,4,5,6,7,8,9-octahydro-1H-fluoren-9-yl)-

3-Quinolinecarbonitrile,2-amino-4-hydroxy-6-[4-(phenylmethyl)-1-piperazinyl]-

3,7-Octadiene-1,5-diol, 1-phenyl-, (1S,3E,5S)-

3,8-Dioxa-2,9-disiladecane, 2,2,4,9,9-pentamethyl-7-nonyl-

3,8-Diazabicyclo[3.2.1]octane-3-carboxamide, N,N-diethyl-8-methyl-

1-(2-Morpholin-4-yl-5-(trifluoromethyl)phenyl)-3-(4-nitrophenyl)thiourea

1024414-86-5

3,8,12-Cyclotetradecatriene-1,2-diol,2,8,12-trimethyl-5-(1-methylethyl)-, (1R,2S,3E,5S,8E,12Z)-

3-Quinolinecarbonitrile,2-(1,3-dihydro-2H-isoindol-2-yl)-5,6,7,8-tetrahydro-7,7-dimethyl-5-oxo-

Benzenepropanoic acid, 4-bromo-b-cyano-a-oxo-, ethyl ester

3-Quinolinecarbonitrile,4-(4-fluorophenyl)-1,2,5,6,7,8-hexahydro-7,7-dimethyl-5-oxo-2-thioxo-

3,7-Diazabicyclo[3.3.1]nonane,3-(6-phenyl-3-pyridazinyl)-7-(2-propenyl)-

3,9-Diazabicyclo[4.2.1]nonane, 9-(6-fluoro-3-pyridinyl)-, (1R,6S)-

286945-05-9

Phosphonium, tributylhexadecyl-, cyanide

Methanesulfonamide,N-[3-fluoro-4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]-

3,8,16,18-Nonadecatetraen-2-one,1-cyclopentyl-6,12-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-14-hydroxy-5,7,9,11,13,15-hexamethyl-,(3Z,5S,6S,7S,8Z,11S,12R,13R,14S,15S,16Z)-

(2R,4R)-1-BOC-2-hydroxyMethyl-4-aMino Pyrrolidine-HCl

3-Quinolinecarbonitrile,6-[[2-(methylthio)-4-oxo-5(4H)-thiazolylidene]methyl]-4-(3-pyridinyl)-

Acetonitrile, [(1-methylpropyl)amino]-